rss
Br J Ophthalmol 2003;87:890-892 doi:10.1136/bjo.87.7.890
  • Clinical science
    • Extended reports

Digital analysis of choroidal neovascularisation in consecutive fluorescein angiograms for use in longitudinal clinical trials

  1. C Bellmann1,
  2. D W Miller1,
  3. K Mehltretter1,
  4. F Schütt1,
  5. J Jorzik1,
  6. K Unnebrink2,
  7. F G Holz1
  1. 1Department of Ophthalmology, University of Heidelberg, Germany
  2. 2Coordination Center for Clinical Trials, University of Heidelberg, Germany
  1. Correspondence to: Frank G Holz, MD, Department of Ophthalmology, University of Heidelberg, INF 400, 69120 Heidelberg, Germany; frank_holz{at}med.uni-heidelberg.de
  • Accepted 19 October 2002

Abstract

Background/aims: To document the natural history and to assess the efficacy of interventional therapies in neovascular age related macular degeneration (AMD), an accurate and reproducible method is required for analysis of consecutive fluorescence angiograms. The development and evaluation of an image analysis software for this purpose is described here. It allows for the quantitative analysis of changes in CNV and/or leakage area over time.

Methods: In digitised angiograms, a mouse driven arrow was used to delineate the CNV border. The ratio of the CNV area to the square of the distance between two vessels was automatically calculated by pixel count to compensate for variation in image sizes at different examination times. These results were directly transferred and stored in a database. To assess reproducibility, CNV areas in 20 patients with occult and 20 patients with classic CNV were determined independently by two readers.

Results: There was only marginal variability between observers with this method: the mean deviation was 0.01 pixels for classic CNV (95% CI −0.17 to +0.15, SD 0.35) and 0.55 pixels for occult CNV (95% CI −1.06 to −0.04, SD 1.14).

Conclusions: This practical PC based method allows for quantification of angiographic features such as CNV size in early frames and area of leakage in late frames. Limitations include non-readily defined borders in angiograms of poor image quality or indistinct borders of the hyperfluorescent areas of interest. The software is applicable to future clinical trials where the analysis of neovascular complex changes is required, for example, following therapeutic intervention.

Footnotes

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Free archive
    The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.